These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28081922)

  • 1. Application of Nuclear Magnetic Resonance to Detect Toxigenic Clostridium difficile from Stool Specimens: A Proof of Concept.
    Yang P; Hash S; Park K; Wong C; Doraisamy L; Petterson J; Petti CA; Ward PM; Lee SH; Menon S; She RC
    J Mol Diagn; 2017 Mar; 19(2):230-235. PubMed ID: 28081922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
    Hong G; Park KS; Ki CS; Lee NY
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel molecular assay to diagnose toxigenic strains of Clostridium difficile.
    Eckert C; Devallière T; Syed-Zaidi R; Lalande V; Barbut F
    Anaerobe; 2018 Aug; 52():111-114. PubMed ID: 29936109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an UltraFast LabChip V280 assay for detection of toxigenic Clostridium difficile.
    Xu X; Luo Y; Song X; Ying J; Ye J; Lu Y; Cai J; Ma J; Wang X; Yu W; Wang Y; Jin D
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):279-283. PubMed ID: 30029809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse transcription polymerase chain reaction-based method for selectively detecting vegetative cells of toxigenic Clostridium difficile.
    Senoh M; Kato H; Murase T; Hagiya H; Tagashira Y; Fukuda T; Iwaki M; Yamamoto A; Shibayama K
    Microbiol Immunol; 2014 Nov; 58(11):615-20. PubMed ID: 25145894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection and characterization of toxigenic Clostridium difficile directly from clinical stool specimens.
    Lai H; Huang C; Cai J; Ye J; She J; Zheng Y; Wang L; Wei Y; Fang W; Wang X; Tang YW; Luo Y; Jin D
    Front Med; 2018 Apr; 12(2):196-205. PubMed ID: 29058256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.
    Hirvonen JJ; Matero P; Siebert C; Kauppila J; Vuento R; Tuokko H; Boisset S
    Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):783-789. PubMed ID: 27988815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of toxigenic strains of Clostridium difficile in stool specimens.
    Gumerlock PH; Tang YJ; Weiss JB; Silva J
    J Clin Microbiol; 1993 Mar; 31(3):507-11. PubMed ID: 8458943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Qiagen artus C. difficile QS-RGQ Kit for Detection of Clostridium difficile Toxins A and B in Clinical Stool Specimens.
    Jazmati N; Wiegel P; Ličanin B; Plum G
    J Clin Microbiol; 2015 Jun; 53(6):1942-4. PubMed ID: 25809977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.
    Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.
    Neuendorf M; Guadarrama-Gonzalez R; Lamik B; MacKenzie CR
    BMC Microbiol; 2016 Feb; 16():19. PubMed ID: 26868647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    Russello G; Russo A; Sisto F; Scaltrito MM; Farina C
    New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.
    Ylisiurua P; Koskela M; Vainio O; Tuokko H
    Scand J Infect Dis; 2013 Jan; 45(1):19-25. PubMed ID: 22998479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.
    Doing KM; Hintz MS
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):8-13. PubMed ID: 22015321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.